News &amp; Updates

Exposure to any antibiotics appears to contribute to an increase in the risk of esophageal adenocarcinoma (EAC), with the risk rising as the cumulative days of exposure increases, according to a study.

Original New Drug Application Approvals by US FDA (16-31 March 2023)

New drug applications approved by US FDA as of 16-31 March 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Tenofovir disoproxil fumarate as good as entecavir for patients with HBV-related liver cancer

Treatment with tenofovir disoproxil fumarate (TDF) yields similar rates of recurrence and overall survival as does entecavir in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), according to a study.

Chemo-induced nausea? Putting on some music may help, study suggests

For people undergoing chemotherapy, tuning in to some music may help soothe nausea symptoms, as reported in a small pilot study.

30 Mar 2023

Young adults with SLE at higher risk of 30-day rehospitalization

A Medicare cohort study has found a very high 30-day rehospitalization rate among young adults with systemic lupus erythematosus (SLE).

30 Mar 2023

Ceftolozane/tazobactam safe, effective in complicated UTI

Combination therapy with ceftolozane and tazobactam demonstrates a favourable safety profile in children with complicated urinary tract infection (cUTI) similar to that of meropenem and to the previously reported safety profile in adults with cUTI, a study has shown.

30 Mar 2023

Sweetened drink fructose tied to harmful levels of cardiometabolic biomarkers

Consumption of fructose from sweetened beverages contributes to unfavourable profiles of several cardiometabolic biomarkers, reveals a study.

Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen

In a systematic review and individual patient data meta-analysis, the broad-spectrum antiviral agent remdesivir reduced mortality in adult patients hospitalized for COVID-19 who did not require oxygen support or only required low-flow supplementation when the need for oxygen arose.

30 Mar 2023

Low-concentration atropine eye drops may reduce myopia incidence in high-risk children

Researchers from the Chinese University of Hong Kong (CUHK) have conducted the world’s first study to show that nightly use of low-concentration (0.05 percent) atropine eye drops may reduce the incidence of myopia in high-risk children.